2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

Writing Committee; Donald M Lloyd-Jones; Pamela B Morris; Christie M Ballantyne; Kim K Birtcher; David D Daly Jr; Sondra M DePalma; Margo B Minissian; Carl E Orringer; Sidney C Smith Jr

doi:10.1016/j.jacc.2016.03.519

2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

J Am Coll Cardiol. 2016 Jul 5;68(1):92-125. doi: 10.1016/j.jacc.2016.03.519. Epub 2016 Apr 1.

Authors

Writing Committee; Donald M Lloyd-Jones, Pamela B Morris, Christie M Ballantyne, Kim K Birtcher, David D Daly Jr, Sondra M DePalma, Margo B Minissian, Carl E Orringer, Sidney C Smith Jr

PMID: 27046161
DOI: 10.1016/j.jacc.2016.03.519

No abstract available

Keywords: ACC Expert Consensus Decision Pathway; ASCVD; LDL-C; PCSK9 inhibitors; bile acid sequestrants; cholesterol; dyslipidemia; ezetimibe; lipids; statins.

Publication types

Review

MeSH terms

American Heart Association*
Anticholesteremic Agents / therapeutic use*
Atherosclerosis / blood
Atherosclerosis / drug therapy*
Cardiology*
Cholesterol, LDL / blood*
Cholesterol, LDL / drug effects
Consensus Development Conferences as Topic*
Consensus*
Decision Support Techniques
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
United States

Substances

Anticholesteremic Agents
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors